Ameriprise’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $757K | Sell |
52,237
-1,003
| -2% | -$11.6K | ﹤0.01% | 3418 |
|
|
2025
Q4 | $512K | Buy |
53,240
+20,251
| +61% | +$194K | ﹤0.01% | 3613 |
|
|
2025
Q3 | $310K | Sell |
32,989
-8,373
| -20% | -$80K | ﹤0.01% | 3789 |
|
|
2025
Q2 | $438K | Buy |
41,362
+1,820
| +5% | +$23K | ﹤0.01% | 3572 |
|
|
2025
Q1 | $594K | Sell |
39,542
-6,551
| -14% | -$109K | ﹤0.01% | 3418 |
|
|
2024
Q4 | $759K | Buy |
46,093
+20,663
| +81% | +$408K | ﹤0.01% | 3364 |
|
|
2024
Q3 | $628K | Sell |
25,430
-5,891
| -19% | -$153K | ﹤0.01% | 3407 |
|
|
2024
Q2 | $793K | Sell |
31,321
-8,203
| -21% | -$213K | ﹤0.01% | 3250 |
|
|
2024
Q1 | $1M | Sell |
39,524
-83,571
| -68% | -$2.02M | ﹤0.01% | 3166 |
|
|
2023
Q4 | $2.79M | Sell |
123,095
-121,418
| -50% | -$2.51M | ﹤0.01% | 2703 |
|
|
2023
Q3 | $4.56M | Sell |
244,513
-48,052
| -16% | -$997K | ﹤0.01% | 2351 |
|
|
2023
Q2 | $7.6M | Buy |
292,565
+84,364
| +41% | +$2.26M | ﹤0.01% | 2019 |
|
|
2023
Q1 | $5.98M | Buy |
208,201
+26,258
| +14% | +$782K | ﹤0.01% | 2195 |
|
|
2022
Q4 | $5.38M | Sell |
181,943
-9,417
| -5% | -$268K | ﹤0.01% | 2242 |
|
|
2022
Q3 | $4.55M | Sell |
191,360
-21,593
| -10% | -$497K | ﹤0.01% | 2287 |
|
|
2022
Q2 | $4.75M | Sell |
212,953
-4,928
| -2% | -$110K | ﹤0.01% | 2324 |
|
|
2022
Q1 | $5.47M | Sell |
217,881
-769,767
| -78% | -$23.5M | ﹤0.01% | 2365 |
|
|
2021
Q4 | $35.4M | Sell |
987,648
-7,309
| -0.7% | -$293K | 0.01% | 1010 |
|
|
2021
Q3 | $42.3M | Sell |
994,957
-2,215
| -0.2% | -$91.2K | 0.01% | 848 |
|
|
2021
Q2 | $43.2M | Sell |
997,172
-183
| -0% | -$7.79K | 0.01% | 873 |
|
|
2021
Q1 | $40.7M | Sell |
997,355
-6,753
| -0.7% | -$256K | 0.01% | 861 |
|
|
2020
Q4 | $45.4M | Sell |
1,004,108
-2,831
| -0.3% | -$107K | 0.02% | 779 |
|
|
2020
Q3 | $35.6M | Buy |
1,006,939
+93,574
| +10% | +$3.38M | 0.01% | 779 |
|
|
2020
Q2 | $34.5M | Buy |
913,365
+269,074
| +42% | +$8.87M | 0.01% | 766 |
|
|
2020
Q1 | $18.6M | Buy |
644,291
+66,403
| +11% | +$2.69M | 0.01% | 976 |
|
|
2019
Q4 | $30M | Sell |
577,888
-67,695
| -10% | -$3.93M | 0.01% | 935 |
|
|
2019
Q3 | $35.4M | Sell |
645,583
-355,496
| -36% | -$18.3M | 0.02% | 814 |
|
|
2019
Q2 | $40.7M | Buy |
1,001,079
+356,686
| +55% | +$13M | 0.02% | 773 |
|
|
2019
Q1 | $19.5M | Buy |
644,393
+438,849
| +214% | +$15M | 0.01% | 1162 |
|
|
2018
Q4 | $6.91M | Buy |
205,544
+4,707
| +2% | +$170K | ﹤0.01% | 1897 |
|
|
2018
Q3 | $8.47M | Buy |
200,837
+2,401
| +1% | +$94.9K | ﹤0.01% | 2005 |
|
|
2018
Q2 | $6.35M | Sell |
198,436
-146,311
| -42% | -$6.03M | ﹤0.01% | 2072 |
|
|
2018
Q1 | $17.1M | Buy |
344,747
+228,253
| +196% | +$12.9M | 0.01% | 1237 |
|
|
2017
Q4 | $6.28M | Sell |
116,494
-2,715
| -2% | -$150K | ﹤0.01% | 1967 |
|
|
2017
Q3 | $6.91M | Sell |
119,209
-7,594
| -6% | -$397K | ﹤0.01% | 1843 |
|
|
2017
Q2 | $6.26M | Buy |
126,803
+8,347
| +7% | +$384K | ﹤0.01% | 1907 |
|
|
2017
Q1 | $5.15M | Buy |
118,456
+26,362
| +29% | +$1.26M | ﹤0.01% | 2027 |
|
|
2016
Q4 | $4.51M | Buy |
92,094
+19,009
| +26% | +$879K | ﹤0.01% | 2123 |
|
|
2016
Q3 | $3.5M | Buy |
73,085
+525
| +0.7% | +$25.9K | ﹤0.01% | 2245 |
|
|
2016
Q2 | $3.89M | Sell |
72,560
-17,023
| -19% | -$802K | ﹤0.01% | 2131 |
|
|
2016
Q1 | $4.01M | Buy |
89,583
+22,008
| +33% | +$893K | ﹤0.01% | 2111 |
|
|
2015
Q4 | $2.58M | Sell |
67,575
-2,053
| -3% | -$78.5K | ﹤0.01% | 2452 |
|
|
2015
Q3 | $2.22M | Sell |
69,628
-367
| -0.5% | -$12.8K | ﹤0.01% | 2560 |
|
|
2015
Q2 | $2.31M | Sell |
69,995
-395
| -0.6% | -$14.1K | ﹤0.01% | 2659 |
|
|
2015
Q1 | $2.9M | Buy |
70,390
+4,666
| +7% | +$189K | ﹤0.01% | 2399 |
|
|
2014
Q4 | $2.68M | Sell |
65,724
-15,611
| -19% | -$610K | ﹤0.01% | 2417 |
|
|
2014
Q3 | $2.98M | Buy |
81,335
+15,170
| +23% | +$656K | ﹤0.01% | 2330 |
|
|
2014
Q2 | $3.06M | Buy |
66,165
+18,983
| +40% | +$844K | ﹤0.01% | 2344 |
|
|
2014
Q1 | $1.94M | Buy |
47,182
+2,339
| +5% | +$86.9K | ﹤0.01% | 2496 |
|
|
2013
Q4 | $1.71M | Buy |
44,843
+44,094
| +5,887% | +$1.36M | ﹤0.01% | 2508 |
|
|
2013
Q3 | $18K | Sell |
749
-6,590
| -90% | -$148K | ﹤0.01% | 4486 |
|
|
2013
Q2 | $126K | Buy |
+7,339
| New | +$106K | ﹤0.01% | 3287 |
|
Other funds holding ANIK
CP
VCM
BFM
CM
Ameriprise's ANIK Position: Q1 2026 in Review
Ameriprise reduced its Anika Therapeutics (ANIK) stake by 1.9% in Q1 2026, selling an estimated $11.6K and leaving 52,237 shares worth $757K. The position accounts for ﹤0.01% of the portfolio, ranked #3418.
Ameriprise first reported a position in ANIK in Q2 2013 and has held it in 52 quarters since. The position peaked at $45.4M in Q4 2020. 130 funds tracked by Wall St. Rank hold ANIK as of Q1 2026.
- Ameriprise held 52,237 shares of Anika Therapeutics worth $757K as of Q1 2026.
- Ameriprise sold 1,003 Anika Therapeutics shares in Q1 2026, an estimated $11.6K.
- Anika Therapeutics made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #3418 holding.
- Ameriprise first reported a position in Anika Therapeutics in Q2 2013 and has held it in 52 quarters since.
- Ameriprise's Anika Therapeutics position peaked at $45.4M in Q4 2020.
- 130 funds tracked by Wall St. Rank held Anika Therapeutics as of Q1 2026.
Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.